Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.025 per share
-
Shares outstanding
-
61.7M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
28.5M
-
Shares change
-
+918K
-
Total reported value, excl. options
-
$625M
-
Value change
-
+$21.3M
-
Number of buys
-
14
-
Number of sells
-
-21
-
Price
-
$22.06
Significant Holders of GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) as of Q3 2021
40 filings reported holding GHRS - GH Research PLC - Ordinary shares, nominal value $0.025 per share as of Q3 2021.
GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.5M shares
of 61.7M outstanding shares and own 46.17% of the company stock.
Largest 10 shareholders include BVF INC/IL (9.28M shares), RA CAPITAL MANAGEMENT, L.P. (3.01M shares), FMR LLC (2.28M shares), RTW INVESTMENTS, LP (2.17M shares), VR Adviser, LLC (1.64M shares), ORBIMED ADVISORS LLC (1.43M shares), CITADEL ADVISORS LLC (1.31M shares), Verition Fund Management LLC (1.26M shares), BOXER CAPITAL, LLC (1.01M shares), and Cormorant Asset Management, LP (608K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.